In response to recent outbreaks of meningitis B that resulted in three fatalities, the UK government is launching a one-off vaccination programme for school leavers and new university students. Starting in late July, eligible individuals born between September 1, 2007, and August 31, 2008, will receive two doses of the Bexsero vaccine, which protects against most strains of MenB bacteria.
The initiative aims to mitigate the risk of serious illness as students transition to university life, where the risk of infection is heightened due to shared living spaces and social activities. Health Secretary James Murray emphasised the urgency of this programme, highlighting that cases of invasive meningococcal disease typically peak in the autumn months.
This vaccination effort is particularly significant as it marks a proactive approach to public health, addressing a potential shift in how MenB affects young people. While the MenB vaccine has been part of routine immunisations for infants since 2015, this is the first time it will be offered to older teenagers and young adults in such a targeted manner.
Experts have noted that while this is an emergency response rather than a routine vaccination, it could pave the way for future expansions of the MenB vaccination programme. The NHS will contact eligible individuals directly, ensuring that students can easily access this vital protection before the academic year begins.
Source: The Guardian
